Other Clinical Trial - Ursodeoxycholic Acid in C. Difficile Infection

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03895593` - Rescue Fecal Microbiota Transplantation for National Refractory Intestinal Infections
Withdrawn	`NCT04679324` - The Role of Mucosal Microbiome in the Development, Clearance and Recurrence of Clostridioides Difficile Infection
Completed	`NCT04675723` - The Role of Mucosal Microbiome in Recurrence of Clostridioides Difficile Infection
Recruiting	`NCT05693077` - Clostridioides Difficile Colonisation	Phase 1
Completed	`NCT04668014` - The Characteristics and Role of Mucosal Microbiome After Treatment of Clostridioides Difficile Infection
Completed	`NCT03183141` - ECOSPOR IV: An Open-Label Study Evaluating SER-109 in Recurrent Clostridioides Difficile Infection	Phase 3
Recruiting	`NCT05709184` - Lyophilized Fecal Microbiome Transfer vs. Vancomycin Monotherapy for Primary Clostridioides Difficile Infection	N/A
Recruiting	`NCT06306014` - Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk Patients	Phase 1/Phase 2
Recruiting	`NCT06237452` - VE303 for Prevention of Recurrent Clostridioides Difficile Infection	Phase 3
Terminated	`NCT04802837` - Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent Subjects	Phase 3
Active, not recruiting	`NCT04885946` - Fecal Microbiota Transplantation for Early Clostridioides Difficile Infection	N/A
Recruiting	`NCT04305769` - Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)	Phase 2
Recruiting	`NCT06106698` - Washed Microbiota Transplantation for Clostridioides Difficile Infection
Active, not recruiting	`NCT04781387` - Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection	Phase 2
Completed	`NCT03595553` - Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection	Phase 3
Completed	`NCT03595566` - To Compare Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection	Phase 3
Completed	`NCT04725123` - Addressing Personalized Needs in Clostridioides Difficile Infection	N/A
Not yet recruiting	`NCT05852587` - Xylitol Use for Decolonization of C. Difficile in Patients With IBD	Phase 1
Completed	`NCT03788434` - Phase 2 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection	Phase 2
Recruiting	`NCT05612672` - Evaluation of GeoHAI Implementation	N/A

NCT number	NCT05526807
Study type	Interventional
Source	Nottingham University Hospitals NHS Trust
Contact
Status	Terminated
Phase	N/A
Start date	May 8, 2019
Completion date	December 31, 2023

Ursodeoxycholic Acid in C. Difficile Infection

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms